CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
3 Mar, 20:00
NYSE NYSE
$
80. 49
-1.17
-1.43%
$
96.93B Market Cap
11.4 P/E Ratio
0.97% Div Yield
7,086,834 Volume
7.87 Eps
$ 81.66
Previous Close
Day Range
79.2 81.69
Year Range
58.35 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS earnings report is expected in 56 days (29 Apr 2026)
Are Medical Stocks Lagging CVS Health (CVS) This Year?

Are Medical Stocks Lagging CVS Health (CVS) This Year?

Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.

Zacks | 8 months ago
3 High-Yield Dividend Kings Beating the S&P 500 This Year

3 High-Yield Dividend Kings Beating the S&P 500 This Year

The S&P 500 is one of the most widely known benchmarks. It contains the 500 most valuable publicly traded U.S.

247wallst | 8 months ago
CVS Health (CVS) Laps the Stock Market: Here's Why

CVS Health (CVS) Laps the Stock Market: Here's Why

CVS Health (CVS) closed the most recent trading day at $67.58, moving +1.15% from the previous trading session.

Zacks | 8 months ago
Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 8 months ago
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 8 months ago
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?

Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?

CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.

Zacks | 8 months ago
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?

CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?

CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.

Zacks | 8 months ago
5 Low Price-to-Book Value Stocks That You Can Buy in June

5 Low Price-to-Book Value Stocks That You Can Buy in June

The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.

Zacks | 8 months ago
4 Attractive GARP Picks for Your Portfolio Based on PEG Ratio

4 Attractive GARP Picks for Your Portfolio Based on PEG Ratio

Here are four discounted PEG stocks that qualify our screening criteria and could be good picks. These are FLEX, CVS, URBN and EXEL.

Zacks | 8 months ago
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends?

CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends?

CVS posts its first favorable MBR in quarters, but elevated cost trends test its ability to sustain the gains.

Zacks | 8 months ago
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?

CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?

CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.

Zacks | 9 months ago
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 9 months ago
Loading...
Load More